Addus HomeCare (NASDAQ:ADUS) Upgraded by StockNews.com to “Buy” Rating

StockNews.com upgraded shares of Addus HomeCare (NASDAQ:ADUS) from a hold rating to a buy rating in a research report sent to investors on Friday morning.

Other equities analysts also recently issued reports about the stock. Stephens increased their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. JMP Securities initiated coverage on shares of Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective for the company. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Macquarie restated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, KeyCorp initiated coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $134.22.

Addus HomeCare Trading Up 2.8 %

ADUS stock opened at $130.62 on Friday. The stock has a 50-day moving average price of $126.10 and a two-hundred day moving average price of $126.96. The stock has a market cap of $2.37 billion, a PE ratio of 29.89, a price-to-earnings-growth ratio of 1.73 and a beta of 1.00. Addus HomeCare has a 1 year low of $85.94 and a 1 year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.03 EPS. On average, analysts forecast that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock worth $4,930,750 over the last three months. Insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Quarry LP bought a new position in shares of Addus HomeCare during the third quarter worth approximately $28,000. Farther Finance Advisors LLC increased its stake in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares during the last quarter. KBC Group NV increased its stake in Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after acquiring an additional 268 shares during the last quarter. GAMMA Investing LLC increased its stake in Addus HomeCare by 25.7% in the third quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock valued at $124,000 after acquiring an additional 191 shares during the last quarter. Finally, Assetmark Inc. increased its stake in Addus HomeCare by 11.5% in the third quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after acquiring an additional 121 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.